Skip to main content
Clinical Trials/NCT01735539
NCT01735539
Unknown
Not Applicable

Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People; The Role of Essential Amino Acids in Modulating Muscle Protein Metabolism; Bolus vs. Pulse Feeding Strategies and the Ability of Arginine to Rejuvenate Microvascular Responsiveness.

University of Nottingham1 site in 1 country40 target enrollmentDecember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Old Age (Focus; Not a Recognized Condition)
Sponsor
University of Nottingham
Enrollment
40
Locations
1
Primary Endpoint
Muscle Protein Synthesis (FSR, fractional synthetic rate, %/hr)
Last Updated
12 years ago

Overview

Brief Summary

The investigators plan to measure changes in muscle protein metabolism in response to feeding, comparing between a single large essential amino acid (EAA) feed (the normal building blocks of protein) and the provision of the same dose in 4 smaller feeds at 45min intervals. The investigators will perform this study in healthy older (65-75y) and younger (18-28) men. The investigators will also explore how feeding affects muscle blood flow as this is important in the delivery of the nutrients we eat to the muscle where they are used.

The investigators plan to supplement the feed with arginine, a safe and widely found non-essential amino acid, to explore if this can improve muscle blood flow.

Detailed Description

We will provide a 15g mixed essential amino acid feed or 4 x 3.75g. There is sexual dimorphism thus initially we will just recruit males. Powering calculations dictate n=8 in each group. We will use well established stable isotope tracer techniques (with 13C6 Phenylalanine) to measure muscle protein synthesis and breakdown by Gas Chromatography - combustion - isotope ratio mass spectroscopy. We will measure leg blood flow by phase shift Doppler and muscle microvascular flow by contrast enhanced ultrasound.

Registry
clinicaltrials.gov
Start Date
December 2011
End Date
January 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age 65-75 or 18-28

Exclusion Criteria

  • Beta blocker or steroid use
  • Established cerebrovascular, peripheral vascular or ischaemic heart disease.

Outcomes

Primary Outcomes

Muscle Protein Synthesis (FSR, fractional synthetic rate, %/hr)

Time Frame: Across 6hr study

We measure FSR when fasted and again 0-90, 90-180 and 180-240 post feed.

Secondary Outcomes

  • Muscle Protein Breakdown (MPB)(Across 6hr study)
  • Muscle Microvascular Blood flow(Across a 6hr study)
  • Whole leg blood flow(Across a 6hr study)

Study Sites (1)

Loading locations...

Similar Trials